Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Profound Medical Corp
(TSX:
PRN
)
9.140
-0.420 (-4.39%)
Streaming Delayed Price
Updated: 11:01 AM EDT, Jun 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Profound Medical Corp
< Previous
1
2
3
4
Next >
Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer
October 16, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical’s PRO-Talk Live! Event Features the Present and Future of TULSA
September 16, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in Lake Street’s Best Ideas Growth Conference
September 04, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Second Quarter 2024 Financial Results
August 08, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow
July 18, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases
July 11, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Annual General Meeting of Shareholders Voting Results
May 15, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan
May 14, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance
May 09, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum
May 06, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow
April 22, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 09, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results
March 07, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference
March 04, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure
February 27, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow
February 15, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Non-Brokered Private Placement
January 16, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
BioMedNewsBreaks – Profound Medical Corp. (TSX: PRN) (NASDAQ: PROF) Announces Pricing of US$20M Public Offering
January 04, 2024
Via
Investor Brand Network
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues
January 03, 2024
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares
December 27, 2023
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Proposed Public Offering of Common Shares
December 27, 2023
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in the Stifel 2023 Healthcare Conference
November 08, 2023
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting
November 03, 2023
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces Third Quarter 2023 Financial Results
November 02, 2023
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow
October 19, 2023
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical 2023 Virtual Analyst & Investor Day Agenda
October 10, 2023
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost
September 25, 2023
The first of the TULSA AI modules, Thermal Boost enables predictable, customized ablation at the prostate capsule
From
Profound Medical Corp.
Via
GlobeNewswire
Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13
September 21, 2023
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference
September 19, 2023
From
Profound Medical Corp.
Via
GlobeNewswire
Profound Medical Announces At-the-Market Offering of up to US$30,000,000
September 06, 2023
From
Profound Medical Corp.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
